Introduction {#sec1-1}
============

Psoriasis is an inflammatory and proliferative skin disease with heterogeneous genetic background and is characterised by chronic, sharply demarcated, dull-red scaly plaques on the skin and particularly on the extensor prominences and in the scalp area \[[@ref1]\]. It is one of the most common chronic skin diseases in need of long-term therapy. Although the multi-factorial aetiology of this disease, a strong association between body mass index and psoriasis severity was shown \[[@ref7]\]. Until now there has not been an ideal treatment for this perplexing ailment.

However, a variety of therapeutic approaches have shown limited efficacy with frequent side effects. *In vivo* and *in vitro* data prove the effectiveness of cytokines taken in low-doses \[[@ref1]\] and antioxidants \[[@ref2]\] Complementary therapy based on psychotherapeutic approaches has also shown to be effective \[[@ref3]\].

The use of apitherapy (using hive products for medical and pharmacological purposes) remains a controversial matter in the treatment of dermatological diseases especially psoriasis \[[@ref5]\].

Aloe vera is a plant that has been used in folk medicine; its mucilaginous gel is used for treating itching, hair loss and many other problems. It is also found in modern-day commercial beauty products.

Aloe vera has also proven effective on the cutaneous burn and wound healing \[[@ref6]\]. There have been many studies that demonstrated considerable analgesic, antipruritic, wound healing and anti-inflammatory properties \[[@ref4]\]. These qualities justify investigating Aloe vera in the treatment of psoriasis.

This study aims to evaluate the efficacy of a combined natural topical treatment for psoriasis. The drug is mainly composed of propolis (one of the most important hive products) and Aloe vera. The ointment is used for topical treatment of mild to moderate psoriasis in all regions of the body except face and genitalia.

Material and Methods {#sec1-2}
====================

In a double-blind placebo-controlled study, 2248 patients of the Center of Dermatology in Heliopolis (Cairo, Egypt), with mild to moderate psoriasis have been included. Patients from 2012 to 2015 were divided into two groups. Group I was treated with an ointment containing a combination of propolis 50% and Aloe vera 3%. Group was II treated with a placebo (ointment without propolis and Aloe vera). Topical treatment was performed for 12 weeks while sparing face and genital.

Definition of clinical outcome:

Excellent response: when all psoriatic lesions disappeared, and skin becomes nearly normal (no erythema, no infiltration or desquamation of skin).Good response: when some of the lesions disappeared.Weak response: when no marked improvement in erythema, infiltration or desquamation of skin was noted.No response: when no response occurred at all.

The outcome was also evaluated by psoriasis area and severity-score (PASI score) and skin biopsies.

Results {#sec1-3}
=======

In Group 1 the overall response at the end of 12 weeks was as follows: Cleared in 64.4% (excellent response), good response in 22.2%, and weak response in 5.6% and no response in 7.7% (Figures [1](#F1 F2 F3 F4 F5){ref-type="fig"}-[6](#F6){ref-type="fig"}).

![Clinical results of treatment](OAMJMS-6-839-g001){#F1}

![Results of treatment. Percentage of PASI-reduction](OAMJMS-6-839-g002){#F2}

![Histology pre and post-treatment (Biopsy Rt.Sole; HE stain). Within the typical plaque, psoriatic epidermis shows marked epidermal acanthosis, hyperkeratosis, and elongation; the presence of Munro's microabscesses (to the left). Parakeratosis changed to orthokeratosis, acanthosis decreased, the rate ridges became shorter than before TTT; absence of Munro's microabscesses (to the right)](OAMJMS-6-839-g003){#F3}

![Pre (left) and post (right) 3 months of treatment](OAMJMS-6-839-g004){#F4}

![Pre (left) and post (right) 3 months of treatment](OAMJMS-6-839-g005){#F5}

![Pre (left) and post (right) 3 months of treatment](OAMJMS-6-839-g006){#F6}

The formulation resulted in significant reduction of erythema and scaling. In Group 2 (placebo group) no significant improvement was observed after 12 weeks of treatment. Also, histology also demonstrated a marked reduction in hyperkeratosis and acanthosis.

The ointment worked for different types of lesions ([Table 1](#T1){ref-type="table"}).

###### 

Results of treatment I relation to the type of psoriasis lesions

  Type          Result      Total          
  ------------- ----------- ------- ------ ------
  Guttate       Excellent   183            183
  Good          24                  24     
  Weak                      7       7      
  No Response               11      11     
  Total         207         18      225    
  Palmo         Excellent   246            246
  Good          95                  95     
  Weak                      12      12     
  No Response               38      38     
  Total         341         50      391    
  Plaque        Excellent   1021           1021
  Good          380                 380    
  Weak                      107     107    
  No Response               124     124    
  Total         1401        231     1632   

We used Psoriasis Area and Severity Index (PASI score) as a method of clinical assessment of patients.

This is purely clinical rating system which assesses the area of the body affected by the intensity of the main symptoms.

###### 

reduction of PASI score

  %- Reduction of PASI score   Cases   Percent
  ---------------------------- ------- ---------
  Effective                    1947    86.70%
  Non-effective                301     13.30%
  Total                        2248    100%

A punch biopsy was taken before application of the treatment and stained to be examined histologically ([Figure 3](#F3){ref-type="fig"}).

Discussion {#sec1-4}
==========

Psoriasis is a common systemic inflammatory disorder. In this double-blind placebo-controlled study 2248 patients with mild to moderate psoriasis were enrolled. Group 1 received topical treatment with an ointment containing a combination of propolis and aloe vera. Group 2 received placebo (ointment without aforementioned active compounds. We excluded only facial and genital skin. Tolerability of the treatment was very good.

Major natural constituents have been used in this trial. The first one is propolis, a non-toxic substance which is composed of resins, waxes and fatty acids, minerals, vitamins, and flavonoids. Flavonoids, caffeic acid-phenethyl ester (CAPE), and hydroxycinnamic acid are responsible for most biological effects including with anti-inflammatory activity. CAPE has both anti-inflammatory and anti-oxidative properties. Since CAPE is lipophilic, it is capable of inhibiting the intracellular LOX and COX enzymes, and thereby indirectly the arachidonic pathway. This action prevents the release of prostaglandins and leukotrienes, and it decreases neutrophil infiltration into the skin \[[@ref4]\] \[[@ref9]\].

No severe side effects were noted. Minimal discomfort due to the texture of the ointment and temporal itching sensation had been observed.

The other natural ingredients were Aloe vera. Aloe vera has moisturising qualities, which are helpful in restoring disturbed skin barrier function. Aloesin from Aloe vera positively regulated the release of cytokines and growth factors (IL-1β, IL-6, TGF-β1 and TNF-α) from macrophages and enhanced angiogenesis in endothelial cells (HUVECs). Aloesin accelerates wound closure in mice by activating Smad and MAPK signalling proteins that are of utmost importance in cell migration, angiogenesis and tissue development \[[@ref10]\].

Topical Aloe vera was more effective in PASI reduction in moderate plaque psoriasis in a randomised, comparative, double-blind 8-weeks trial than 0.1% triamcinolone acetonide \[11\]. These results are supported by the present study.

In comparison with Group 2 (placebo group) patients in Group 1, treated with a mixture of propolis (50%) and aloe vera (3%), in the form of an ointment have shown noteworthy improvement thus substantiating the therapeutic value of propolis and aloe vera in the treatment of mild to moderate psoriasis.
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